Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

Subjects: GILEAD Sciences Inc.; COVID-19; REMDESIVIR

  • Source: New England Journal of Medicine. 11/5/2020, Vol. 383 Issue 19, p1827-1837. 11p.

  • Abstract: Background: Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
Academic Journal

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

Subjects: *COVID-19; *REMDESIVIR; *RNA polymerases

  • Source: New England Journal of Medicine. 6/11/2020, Vol. 382 Issue 24, p2327-2336. 10p.

  • Abstract: BACKGROUND Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
  • 1-2 of  2 results for ""RNA polymerases""